You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 14, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Hui Lu1,2,3,4,5,6, Jin Zhang1,2,3,4,5,6, Tianzhuo Shen1,2,3,4,5,6
1Institute of Translational Medicine, Shanghai University, Shanghai 200444, China.
Artificial intelligence (AI) offers new solutions for challenges in extracellular vesicle (EV) research. AI applications in EV target identification, drug delivery, and data analysis promise to advance EV-based disease diagnosis and treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: